Close Topic Options

Johnson & Johnson's - Page 2

Halt on Johnson & Johnson's COVID-19 vaccine to continue until more data on rare blood clotting disorder is available. A CDC committee decided to take no action Wednesday, leaving in place a pause on J&J's COVID-19 vaccine so they can gather more information on a rare blood clotting side effect. Ref. USAToday.

Johnsons and Johnson

CDC advisers recommend resuming use of J&J’s coronavirus vaccine; FDA to add blood clot warning. Vaccine advisers to the US Centers for Disease Control and Prevention voted Friday to recommend resuming use of the vaccine. An updated warning will be added to the label. The CDC and US Food and Drug Administration recommended pausing the use of the vaccine on April 13 while they investigated the risk of rare, severe… Source 2j.

Johnson & Johnson's History & Civil Business Politics

Good luck trying to get apprehensive people to take their vaccine knowing there is a risk for blood clots that can kill them within hours.

Page 2 Johnsons and Johnson

Thirteen more cases of an unusual blood clotting disorder were identified among people who got the Johnson & Johnson vaccine, all before an 11-day pause in its use. Source 7n.

Johnsons and Johnson

A booster dose of the Johnson & Johnson vaccine produced a ninefold increase in antibodies, company says. Johnson & Johnson said Wednesday that studies showed a booster dose of its vaccine showed "A rapid and robust increase in spike-binding antibodies, ninefold higher than 28 days after the primary single-dose vaccination." The company said it was working with federal officials on next steps to boost the effects of the vaccine and ready a possible booster shot. Ref. USAToday.